BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2691 related articles for article (PubMed ID: 7685328)

  • 1. Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines.
    Scheibenbogen C; Keilholz U; Meuer S; Dengler T; Tilgen W; Hunstein W
    Int J Cancer; 1993 May; 54(3):494-8. PubMed ID: 7685328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of human MEL-7 melanoma metastasis in nude and beige/nude mice].
    Bryzgalov IP; Sorokina IuD; Solov'ev IuN; Revazova ES
    Biull Eksp Biol Med; 1996 Jan; 121(1):89-90. PubMed ID: 8680015
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytodiagnosis of malignant melanoma of soft tissue: report of a case with diagnosis by intraoperative cytology.
    Ishi K; Suzuki F; Saito A; Koyatsu J; Kina K; Shitoto K
    Acta Cytol; 1998; 42(5):1177-80. PubMed ID: 9755678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cultured cells derived from Mongolian gerbil's (Meriones unguiculatus) ascitic malignant melanoma.
    Hashimoto O; Miyamoto K; Moritomo T; Saito H; Watanabe T; Mochizuki K
    J Vet Med Sci; 1993 Apr; 55(2):227-32. PubMed ID: 8513002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fixation on interphase cytogenetic analysis by direct fluorescence in situ hybridization on cell imprints.
    Kapranos N; Kontogeorgos G; Frangia K; Kokka E
    Biotech Histochem; 1997 May; 72(3):148-51. PubMed ID: 9187738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of novel and conventional anti-cancer agents on human endothelial permeability: influence of tumour secreted factors.
    Watts ME; Woodcock M; Arnold S; Chaplin DJ
    Anticancer Res; 1997; 17(1A):71-5. PubMed ID: 9066632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
    Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
    Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanocortin probes for the melanoma MC1 receptor: synthesis, receptor binding and biological activity.
    Erskine-Grout ME; Olivier GW; Lucas P; Sahm UG; Branch SK; Moss SH; Notarianni LJ; Pouton CW
    Melanoma Res; 1996 Apr; 6(2):89-94. PubMed ID: 8791265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of basic fibroblast growth factor in desmoplastic melanoma.
    al-Alousi S; Carlson JA; Blessing K; Cook M; Karaoli T; Barnhill RL
    J Cutan Pathol; 1996 Apr; 23(2):118-25. PubMed ID: 8721445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimetabolite Tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells.
    Tímár J; Tóvári J; Pogány G; Ladányi A; Paku S; Rśó E; Bocsi J; Jeney A; Lapis K
    Eur J Cancer; 1996 Jan; 32A(1):152-9. PubMed ID: 8695225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of complications associated with the hydroxyapatite implant.
    Kaltreider SA; Newman SA
    Ophthalmic Plast Reconstr Surg; 1996 Mar; 12(1):18-31. PubMed ID: 8652455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration.
    Caraceni A; Martini C; Belli F; Mascheroni L; Rivoltini L; Arienti F; Cascinelli N
    Eur J Cancer; 1993; 29A(9):1266-9. PubMed ID: 8343265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant.
    Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
    J Cancer Res Clin Oncol; 1994; 120(11):631-5. PubMed ID: 7962038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the new stereological probes to the study of the melanosome in Cloudman S91 melanoma cells.
    Fang D; Dockery P; Weatherhead B
    Pigment Cell Res; 1997; 10(1-2):77-84. PubMed ID: 9170168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galanin--a neuropeptide with inhibitory actions.
    Kask K; Langel U; Bartfai T
    Cell Mol Neurobiol; 1995 Dec; 15(6):653-73. PubMed ID: 8719035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer mortality among Iowa farmers: recent results, time trends, and lifestyle factors (United States).
    Cerhan JR; Cantor KP; Williamson K; Lynch CF; Torner JC; Burmeister LF
    Cancer Causes Control; 1998 May; 9(3):311-9. PubMed ID: 9684711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes.
    Lüscher U; Filgueira L; Juretic A; Zuber M; Lüscher NJ; Heberer M; Spagnoli GC
    Int J Cancer; 1994 May; 57(4):612-9. PubMed ID: 8181865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-thujaplicin zinc chelate induces apoptosis in mouse high metastatic melanoma B16BL6 cells.
    Miyamoto D; Endo N; Oku N; Arima Y; Suzuki T; Suzuki Y
    Biol Pharm Bull; 1998 Dec; 21(12):1258-62. PubMed ID: 9881634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF alpha in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives.
    Eggermont AM
    Anticancer Res; 1998; 18(5D):3899-905. PubMed ID: 9854502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic and anticancer activities of some 1-aryl-2-dimethylaminomethyl-2-propen-1-one hydrochlorides.
    Dimmock JR; Vashishtha SC; Patil SA; Udupa N; Dinesh SB; Devi PU; Kamath R
    Pharmazie; 1998 Oct; 53(10):702-6. PubMed ID: 9812337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 135.